|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||197.70 - 198.56|
|52 Week Range||139.65 - 198.56|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.43%|
DaVita (DVA) reported revenues of ~$2.9 billion in the second quarter of 2018, which is a 6.9% YoY (year-over-year) growth compared to $2.7 billion in the second quarter of 2017. DaVita reported 6.9% growth in its top line to $2.89 billion, including an 11.1% growth in revenues from US dialysis and related lab services to $2.57 billion, offset by a 17.7% decrease in revenues for other ancillary services and strategic initiatives in the second quarter of 2018. Medicare and Medicare Advantage revenues were $1.5 billion in the second quarter of 2018, a 16.2% growth compared to $1.3 billion in the second quarter of 2017.
While technology stocks tend to make the flashiest headlines, the health-care sector remains one of the most consistent outperformers. The top health-care exchange traded fund (ETF) by assets, the $18 billion Health Care Select SPDR ETF (XLV) has gained about 10% this year vs. 6% for the S&P 500 Index (SPX) And longer term, it’s up about 205% in 10 years vs. about 145% for the S&P 500. It’s no surprise, then, that investors closely follow these health-care funds and continue to invest plenty of funds in the leaders.
The healthcare sector and related ETFs have been among the best performing defensive plays this year as strong earnings and potential Trump administration actions on drug pricing drew greater investment ...
Cigna Group (NYSE: CI) agreed to acquire Express Scripts Holdings (NasdaqGS: ESRX), but healthcare sector-specific exchange traded funds remain relatively muted. For instance, the iShares U.S. Healthcare ...
If someone had told you at the beginning of the year that the Republican-controlled Congress was going to try and fail to repeal and replace the Affordable Care Act (ACA) multiple times during 2017, you probably wouldn’t have believed them. You might think that this uncertainty would have taken a bearish toll on healthcare stocks, but you’d be wrong in most cases. Many healthcare stocks are keeping pace with, or outperforming, the S&P 500.
CNBC's Mike Santoli takes a look at which ETFs could be affected by the announcement that J.P. Morgan, Berkshire Hathaway and Amazon are teaming up to form a health-care company.